Humana’s MaxHealth Deal Tests Medicare Advantage Strategy And Valuation Gap

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.

• Humana, ticker NYSE:HUM, is acquiring MaxHealth to expand its CenterWell Senior Primary Care network.

• The move targets rising care costs and tighter government reimbursement rates in its Medicare Advantage business.

• The deal is intended to grow Humana's senior focused primary care footprint through CenterWell Senior Primary Care.

For investors watching NYSE:HUM, this deal comes at a time when the stock trades around $190.54 and longer term returns have been weak, including a 28.0% decline year to date and a 28.6% decline over the past year. Over 3 and 5 years, returns of 60.6% and 50.1% declines respectively underline the pressure on the Medicare Advantage business.

The MaxHealth acquisition provides an example of how Humana is adjusting its business mix toward owned primary care for seniors. As the company integrates MaxHealth into CenterWell Senior Primary Care, investors may focus on how this affects care costs, member retention and the stability of its Medicare Advantage earnings over time.

Stay updated on the most important news stories for Humana by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Humana.

📰 Beyond the headline: 2 risks and 3 things going right for Humana that every investor should see.

Quick Assessment

• ✅ Price vs Analyst Target: At US$190.54 versus a US$223.88 analyst target, the price sits about 15% below consensus.

• ✅ Simply Wall St Valuation: Simply Wall St's model suggests Humana is trading at roughly 81.3% below its estimated fair value.

• ❌ Recent Momentum: The 30 day return of about 1.8% decline signals weak short term momentum.

There is only one way to know the right time to buy, sell or hold Humana. Head to Simply Wall St's company report for the latest analysis of Humana's Fair Value .

Key Considerations

• 📊 The MaxHealth deal expands CenterWell Senior Primary Care, which is central to how Humana manages Medicare Advantage costs and member outcomes.

• 📊 Keep an eye on integration progress, primary care margins and any commentary on how owned clinics affect Medicare Advantage profitability and retention.

• ⚠️ One flagged risk is that Humana's 1.86% dividend is not well covered by free cash flow, so extra investment in clinics could tighten cash further.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Humana analysis . Alternatively, you can check out the community page for Humana to see how other investors believe this latest news will impact the company's narrative.